Setting

Europe CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Country: Trend Forecast and Growth Opportunity

Published: 28 Feb 2022 | Report Code: 10248402 | Pages: 125

Europe CRISPR Gene Editing market was valued at $397.7 million in 2021 and will grow by 27.3% annually over 2021-2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic. Highlighted with 38 tables and 54 figures, this 125-page report “Europe CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe CRISPR Gene Editing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe CRISPR Gene Editing market in every aspect of the classification from perspectives of Offering, Application, End User, and Country. Based on Offering, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • CRISPR Products o Kits & Enzymes ? Vector-Based Cas9 ? DNA-Free Cas9 o Databases & Libraries o Design Tools o Antibodies o CRISPR Plasmid & Vector o Other Products • CRISPR Services o gRNA Design & Vector Construction o Cell Line Engineering o Microbial Gene Editing o DNA Synthesis o Other Services Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Biomedical Research & Therapy o Gene Therapy o Drug Discovery o Diagnostics o Other Biomedical Applications • Agriculture • Industrial Use • Other Applications By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pharmaceutical Companies • Biotechnology Companies • Academic Institutions & Research Centers • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Offering, Application, and End User, over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abcam, Inc. Agilent Technologies, Inc. Applied StemCell, Inc. Caribou Biosciences, Inc. Cellecta, Inc. CRISPR Therapeutics AG Editas Medicine, Inc. GeneCopoeia, Inc. GeneScript Biotech Corporation Horizon Discovery Group PLC Integrated DNA Technologies, Inc. Intellia Therapeutics Inc. Lonza Group Ltd. Merck KGaA New England Biolabs, Inc. Origene Technologies, Inc. Rockland Immunochemicals, Inc. Synthego Corporation System Biosciences LLC Takara Bio, Inc. Thermo Fisher Scientific, Inc. ToolGen, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	22
2.1.2 Impact of COVID-19 on the Market	24
2.2 Major Growth Drivers	26
2.3 Market Restraints and Challenges	35
2.4 Emerging Opportunities and Market Trends	38
2.5 Porter’s Fiver Forces Analysis	42
3 Segmentation of Europe Market by Offering	46
3.1 Market Overview by Offering	46
3.2 CRISPR Products	48
3.2.1 Kits & Enzymes	50
3.2.2 Databases & Libraries	51
3.2.3 Design Tools	52
3.2.4 Antibodies	53
3.2.5 CRISPR Plasmid & Vector	54
3.2.6 Other Products	55
3.3 CRISPR Services	56
3.3.1 gRNA Design & Vector Construction	58
3.3.2 Cell Line Engineering	59
3.3.3 Microbial Gene Editing	60
3.3.4 DNA Synthesis	61
3.3.5 Other Services	62
4 Segmentation of Europe Market by Application	63
4.1 Market Overview by Application	63
4.2 Biomedical Research & Therapy	65
4.2.1 Gene Therapy	67
4.2.2 Drug Discovery	68
4.2.3 Diagnostics	69
4.2.4 Other Biomedical Applications	70
4.3 Agriculture	71
4.4 Industrial Use	72
4.5 Other Applications	73
5 Segmentation of Europe Market by End User	74
5.1 Market Overview by End User	74
5.2 Pharmaceutical Companies	76
5.3 Biotechnology Companies	77
5.4 Academic Institutions & Research Centers	78
5.5 Other End Users	79
6 European Market 2021-2031 by Country	80
6.1 Overview of European Market	80
6.2 Germany	83
6.3 U.K.	85
6.4 France	87
6.5 Spain	89
6.6 Italy	91
6.7 Netherlands	93
6.8 Rest of European Market	95
7 Competitive Landscape	97
7.1 Overview of Key Vendors	97
7.2 New Product Launch, Partnership, Investment, and M&A	101
7.3 Company Profiles	102
Abcam, Inc.	102
Agilent Technologies, Inc.	104
Applied StemCell, Inc.	105
Caribou Biosciences, Inc.	106
Cellecta, Inc.	107
CRISPR Therapeutics AG	108
Editas Medicine, Inc.	109
GeneCopoeia, Inc.	110
GeneScript Biotech Corporation	111
Horizon Discovery Group PLC	112
Integrated DNA Technologies, Inc.	113
Intellia Therapeutics Inc.	114
Lonza Group Ltd.	115
Merck KGaA	116
New England Biolabs, Inc.	117
Origene Technologies, Inc.	118
Rockland Immunochemicals, Inc.	119
Synthego Corporation	120
System Biosciences LLC	121
Takara Bio, Inc.	122
Thermo Fisher Scientific, Inc.	123
ToolGen, Inc.	124
RELATED REPORTS	125
List Of Tables:


Table 1.  Snapshot of Europe CRISPR Gene Editing Market in Balanced Perspective, 2021-2031	18
Table 2. World Economic Outlook, 2021-2031	23
Table 3. Developing Roadmap of CRISPR Technology	27
Table 4. Private and Public Companies Investment in CRISPR Technology	28
Table 5. Comparison of CRISPR with Other Gene Editing Technologies	31
Table 6. World Health Spending by Region, $ bn, 2013-2020	34
Table 7.  Main Product Trends and Market Opportunities in Europe CRISPR Gene Editing Market	38
Table 8. Europe CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	46
Table 9. Europe CRISPR Gene Editing Market: CRISPR Products by Type, 2021-2031, $ mn	49
Table 10. Europe CRISPR Gene Editing Market: Kits & Enzymes by Type, 2021-2031, $ mn	50
Table 11. Europe CRISPR Gene Editing Market: CRISPR Services by Type, 2021-2031, $ mn	57
Table 12. Europe CRISPR Gene Editing Market by Application, 2021-2031, $ mn	63
Table 13. Europe CRISPR Gene Editing Market: Biomedical Research & Therapy by Type, 2021-2031, $ mn	66
Table 14. Europe CRISPR Gene Editing Market by End User, 2021-2031, $ mn	74
Table 15. Europe CRISPR Gene Editing Market by Country, 2021-2031, $ mn	82
Table 16. Germany CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	84
Table 17. Germany CRISPR Gene Editing Market by Application, 2021-2031, $ mn	84
Table 18. Germany CRISPR Gene Editing Market by End User, 2021-2031, $ mn	84
Table 19. U.K. CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	86
Table 20. U.K. CRISPR Gene Editing Market by Application, 2021-2031, $ mn	86
Table 21. U.K. CRISPR Gene Editing Market by End User, 2021-2031, $ mn	86
Table 22. France CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	88
Table 23. France CRISPR Gene Editing Market by Application, 2021-2031, $ mn	88
Table 24. France CRISPR Gene Editing Market by End User, 2021-2031, $ mn	88
Table 25. Spain CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	90
Table 26. Spain CRISPR Gene Editing Market by Application, 2021-2031, $ mn	90
Table 27. Spain CRISPR Gene Editing Market by End User, 2021-2031, $ mn	90
Table 28. Italy CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	92
Table 29. Italy CRISPR Gene Editing Market by Application, 2021-2031, $ mn	92
Table 30. Italy CRISPR Gene Editing Market by End User, 2021-2031, $ mn	92
Table 31. Netherlands CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	94
Table 32. Netherlands CRISPR Gene Editing Market by Application, 2021-2031, $ mn	94
Table 33. Netherlands CRISPR Gene Editing Market by End User, 2021-2031, $ mn	94
Table 34. CRISPR Gene Editing Market in Rest of Europe by Country, 2021-2031, $ mn	96
Table 35. Breakdown of World Market by Key Vendor, 2021, %	99
Table 36. Abcam, Inc.: Company Snapshot	102
Table 37. Abcam, Inc.: Business Segmentation	103
Table 38. Abcam, Inc.: Product Portfolio	103
List Of Figures:


Figure 1. Research Method Flow Chart	12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	17
Figure 4. Europe CRISPR Gene Editing Market, 2021-2031, $ mn	19
Figure 5. Categories of CRISPR-Cas Systems	20
Figure 6. Impact of COVID-19 on Business	24
Figure 7. Primary Drivers and Impact Factors of Europe CRISPR Gene Editing Market	26
Figure 8.  Leading Causes of Death in the World, 2019-2020, million	32
Figure 9.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	33
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060	33
Figure 11. Primary Restraints and Impact Factors of Europe CRISPR Gene Editing Market	35
Figure 12. Investment Opportunity Analysis	39
Figure 13. Porter’s Fiver Forces Analysis of Europe CRISPR Gene Editing Market	42
Figure 14. Breakdown of Europe CRISPR Gene Editing Market by Offering, 2021-2031, % of Revenue	47
Figure 15. Europe Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)	47
Figure 16. Europe CRISPR Gene Editing Market by Offering: CRISPR Products, 2021-2031, $ mn	48
Figure 17. Europe CRISPR Gene Editing Market by CRISPR Products: Kits & Enzymes, 2021-2031, $ mn	50
Figure 18. Europe CRISPR Gene Editing Market by CRISPR Products: Databases & Libraries, 2021-2031, $ mn	51
Figure 19. Europe CRISPR Gene Editing Market by CRISPR Products: Design Tools, 2021-2031, $ mn	52
Figure 20. Europe CRISPR Gene Editing Market by CRISPR Products: Antibodies, 2021-2031, $ mn	53
Figure 21. Europe CRISPR Gene Editing Market by CRISPR Products: CRISPR Plasmid & Vector, 2021-2031, $ mn	54
Figure 22. Europe CRISPR Gene Editing Market by CRISPR Products: Other Products, 2021-2031, $ mn	55
Figure 23. Europe CRISPR Gene Editing Market by Offering: CRISPR Services, 2021-2031, $ mn	56
Figure 24. Europe CRISPR Gene Editing Market by CRISPR Services: gRNA Design & Vector Construction, 2021-2031, $ mn	58
Figure 25. Europe CRISPR Gene Editing Market by CRISPR Services: Cell Line Engineering, 2021-2031, $ mn	59
Figure 26. Europe CRISPR Gene Editing Market by CRISPR Services: Microbial Gene Editing, 2021-2031, $ mn	60
Figure 27. Europe CRISPR Gene Editing Market by CRISPR Services: DNA Synthesis, 2021-2031, $ mn	61
Figure 28. Europe CRISPR Gene Editing Market by CRISPR Services: Other Services, 2021-2031, $ mn	62
Figure 29. Breakdown of Europe CRISPR Gene Editing Market by Application, 2021-2031, % of Sales Revenue	64
Figure 30. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	64
Figure 31. Europe CRISPR Gene Editing Market by Application: Biomedical Research & Therapy, 2021-2031, $ mn	65
Figure 32. Europe CRISPR Gene Editing Market by Biomedical Research & Therapy: Gene Therapy, 2021-2031, $ mn	67
Figure 33. Europe CRISPR Gene Editing Market by Biomedical Research & Therapy: Drug Discovery, 2021-2031, $ mn	68
Figure 34. Europe CRISPR Gene Editing Market by Biomedical Research & Therapy: Diagnostics, 2021-2031, $ mn	69
Figure 35. Europe CRISPR Gene Editing Market by Biomedical Research & Therapy: Other Biomedical Applications, 2021-2031, $ mn	70
Figure 36. Europe CRISPR Gene Editing Market by Application: Agriculture, 2021-2031, $ mn	71
Figure 37. Europe CRISPR Gene Editing Market by Application: Industrial Use, 2021-2031, $ mn	72
Figure 38. Europe CRISPR Gene Editing Market by Application: Other Applications, 2021-2031, $ mn	73
Figure 39. Breakdown of Europe CRISPR Gene Editing Market by End User, 2021-2031, % of Sales Revenue	75
Figure 40. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	75
Figure 41. Europe CRISPR Gene Editing Market by End User: Pharmaceutical Companies, 2021-2031, $ mn	76
Figure 42. Europe CRISPR Gene Editing Market by End User: Biotechnology Companies, 2021-2031, $ mn	77
Figure 43. Europe CRISPR Gene Editing Market by End User: Academic Institutions & Research Centers, 2021-2031, $ mn	78
Figure 44. Europe CRISPR Gene Editing Market by End User: Other End Users, 2021-2031, $ mn	79
Figure 45. Breakdown of European CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue	81
Figure 46. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	82
Figure 47.  CRISPR Gene Editing Market in Germany, 2021-2031, $ mn	83
Figure 48.  CRISPR Gene Editing Market in U.K., 2021-2031, $ mn	85
Figure 49.  CRISPR Gene Editing Market in France, 2021-2031, $ mn	87
Figure 50.  CRISPR Gene Editing Market in Spain, 2021-2031, $ mn	89
Figure 51.  CRISPR Gene Editing Market in Italy, 2021-2031, $ mn	91
Figure 52.  CRISPR Gene Editing Market in Netherlands, 2021-2031, $ mn	93
Figure 53.  CRISPR Gene Editing Market in Rest of Europe, 2021-2031, $ mn	95
Figure 54. Growth Stage of Europe CRISPR Gene Editing Industry over the Forecast Period	97
Selected Key Players: 
Abcam, Inc.
Agilent Technologies, Inc.
Applied StemCell, Inc.
Caribou Biosciences, Inc.
Cellecta, Inc.
CRISPR Therapeutics AG
Editas Medicine, Inc.
GeneCopoeia, Inc.
GeneScript Biotech Corporation
Horizon Discovery Group PLC
Integrated DNA Technologies, Inc.
Intellia Therapeutics Inc.
Lonza Group Ltd.
Merck KGaA
New England Biolabs, Inc.
Origene Technologies, Inc.
Rockland Immunochemicals, Inc.
Synthego Corporation
System Biosciences LLC
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
ToolGen, Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)